The first 120 thousand doses will be launched into civilian circulation in mid-March, the head of the Cabinet said. Mishustin noted that Russia is now the only country in the world that has three registered COVID-19 vaccines. At the moment, about 10 million doses of the Sputnik V vaccine and about 80 thousand doses of the EpiVacCorona drug have already been produced. About 4 thousand vaccination points have been organized throughout the country, Mikhail Mishustin said.
The director of the Chumakov Center, Aydar Ishmukhametov, who attended the cabinet meeting, announced plans to release at least 10 million doses of the KoviVac vaccine by the end of 2021. In the future, the drug may enter the international market.
“I hope that within a year we will nevertheless achieve collective immunity through joint efforts – we are planning to enter international markets. We are the only company – an institute that has prequalification, ”added Ishmukhametov.
The inactivated (whole-virion) vaccine “KoviVac” contains a whole “killed” virus that has lost its infectious properties, but retains the ability to induce an immune response. More than 99% of vaccines worldwide are produced using this technology, including influenza vaccines. Center specialists. Chumakova believe that this approach will allow the formation of a more complete immune response, because antibodies in this case will be produced in response not to one or more viral proteins, but to all proteins contained in the virus.
Vaccines against COVID-19. How to vaccinate?
It usually takes several years for a new vaccine to be released, but there are exceptions everywhere. In 2020, humanity is faced with the novel coronavirus pandemic, and pharmaceutical companies have entered the race trying to create vaccines against COVID-19 in record time. Today, 63 candidates are at various stages of clinical trials, and some of them have already entered the market. Let’s figure out how they differ from each other.
Read the article